Beware of AI Without Expertise

AI is becoming ubiquitous in animal health, from diagnostics and market analysis to due diligence and fundraising. But its value—and its risk—depend heavily on who is using it. Experts rarely accept the first AI-generated answer. They challenge assumptions, test...

Differentiation Can Protect Market Share

As major segments in our industry get crowded and new players with analog molecules or generics enter the market, there is risk of price erosion and segment value reduction. Prescription/purchase decisions based on lowest price carry no brand loyalty. Decisions based...

Trust Still Drives Supplier Relationships

Recently at an internal company event, I had the opportunity to hear a keynote speech from Sarah Furness, a former combat helicopter pilot for the British army. Her presentation was very impressive, and there were a lot of takeaways to think about. One that resonated...

CVS Expands Into Pet Medications

The veterinary clinic pharmacy has gained a new competitor with the announcement that CVS pharmacies are getting into the pet medication business. CVS stores will begin filling prescriptions for many pet products, including parasiticides, dermatology products, pain...

Brakke Viewpoint July 17, 2026

In last week’s Viewpoint, I reviewed the UK’s Competition and Markets Authority (CMA) reforms for the veterinary sector and ended with a comment about trust — it’s not a vague sentiment made on my part. The CMA found that fewer than 50% of clients at large veterinary...

Brakke Viewpoint July 10, 2026

Like a lot of our readers, I consider myself a free-market guy. Let the market decide, keep the government out of markets, and that free and open competition for consumers is good. So, when I read recent articles written about the United Kingdom’s Competition and...
en_USEnglish